Sanofi (SNY) Tax Provisions (2009 - 2026)

Sanofi (SNY) has 18 years of Tax Provisions data on file, last reported at -$491.7 million in Q1 2026.

• Quarterly Tax Provisions rose 2.82% year-over-year to -$491.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 billion (down 26.5% YoY) and the FY2025 annual result came in at $1.2 billion, down 5.63% from the prior year.
• Tax Provisions rose to -$491.7 million in Q1 2026 per SNY's latest filing, from -$1.2 billion in the prior quarter.
• The five-year high for Tax Provisions was -$113.0 million in Q1 2024, with the low at -$2.0 billion in Q4 2022.
• Average Tax Provisions over 5 years is -$720.0 million, with a median of -$506.0 million recorded in 2025.
• Year-over-year, Tax Provisions jumped 77.07% in 2024 and tumbled 347.82% in 2025.
• Sanofi's Tax Provisions stood at -$2.0 billion in 2022, then soared by 46.53% to -$1.1 billion in 2023, then declined by 17.58% to -$1.3 billion in 2024, then advanced by 5.63% to -$1.2 billion in 2025, then jumped by 59.5% to -$491.7 million in 2026.
• Business Quant data shows SNY's Tax Provisions at -$491.7 million in Q1 2026, -$1.2 billion in Q4 2025, and -$1.6 billion in Q3 2025.